| [1] |
Eder, J. P., Teicher, b. A., Holden, S. A. et al. Effects of novobiocin on the antitumor activity and tu-mor cell and bone marrow survivals of three alkylating agent cytotoxicity. Cancer Res, 1991, 51:510.
|
| [2] |
Lee, F. Y. F., Flannery, D. J., and Siemann, D. W. Modulation of the cell cycle-dependent cytotoxicity of adriamycin and 4 hydroperoxyxyclophosphamide by novobiocin, an inhibitor of mammalian topoisomerase I. Cancer Res, 1992, 52:5315.
|
| [3] |
Shibuya, M. L., Buddenbaum, W.E., Don, A. I. et al. Amsacrine-induced lesions in DNA and their modulation by novobiocin and 2, 4-dinitrophenol. Can-cer Res, 1991, 51:573.
|
| [4] |
Stetina, R., and Vesela, D. The influence of DNA-topoisomerase I inhibitors novobiocin and fostriecin on the inducton and repair of DNA damage in Chinese hamster ovary(CHO) cells treated with mitoxantrone. Neoplasma, 1991, 38:109.
|
| [5] |
Smith P. J., Morgan, S. A., Fox, M. E. et al. Mitox-antrone-DNA binding and the induction of topoiso-merase I associated DNA damage in multi-drugs resis-tant small cell lung cancer cells. Biochemical Pharma-cology, 1990, 40:2069.
|
| [6] |
Rowe, T.C., Chen, G. L., Hsiang, Y-H. et al. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase I. Cancer Res, 1986, 46:2021.
|
| [7] |
Rappa, g., Lorico, A., and Sartorelli, A. C. Peteniation by novobiocin of the cytotoxic activity of etoposide (VP16) and tenipside (VM-26). Int. J. Cancer, 1992, 51:780.
|
| [8] |
Woessner, R. D., Chung, T. D. Y., Hofmann, G. A. et al. Differences between normal and ras-tran-formed NIH-3T3 cells in expression of the 170 KD and 180 KD forms of topoisomerase I. Cancer Res, 1990, 50:2901.
|
| [9] |
Downers, C. S., Ord, M. J., Mulligan, A. M. et al. Novobiocin inhibition of excision repair may occur through effects on mitochndrial structure and ATP metabolism, not on repair topoisomerases. Carcinogene-sis, 1985, 6:1343.
|
| [10] |
Sealy, L., Cotten, M., and Chalkley, R. Novobiocin inhibits passive chromatin assembly in vitro. EMBOJ, 1986, 5:3305
|
下载:
